Skip to content

Evaluation of Efficacy and Long-term Safety for the InFo - Instant Focus © Lens / PMCF

Evaluation of Efficacy and Long-term Safety for the InFo - Instant Focus © Lens / PMCF

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02841670
Acronym
INFOLO
Enrollment
30
Registered
2016-07-22
Start date
2016-08-31
Completion date
2019-02-28
Last updated
2019-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cataract

Brief summary

This is a monocentric, longitudinal, prospective, observational post-market follow-up study. 30 patients with a cataract will receive an InFo - Instant Focus © lens implant. After the cataract procedure, data collection will take place during visits planned by the physician as part of normal follow-up. Patients with cataract will be recruited from the clinic by the investigator based on the inclusion and exclusion criteria. The patient will be followed up after one day, one week, one month, six months, one year and three years post-op. An interim analysis will be performed with one-year clinical results. The main objective of the study is to evaluate is to evaluate efficacy and long-term safety for the InFo - Instant Focus © lens.

Interventions

DEVICEInFo - Instant Focus (c) lens implantation

Sponsors

CEISO
CollaboratorINDUSTRY
SAV-IOL SA
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Suffering from cataract * Physician has made the decision to implant on InFo - Instant Focus © lens * Age ≥ 18 years, of either sex * Having given written informed consent, prior to any procedure Non inclusion criteria: * Presenting with an astigmatism of \>1.00D * Presenting contraindications for the implantation of an intraocular lens * Presenting an ophthalmic disorder liable to interfere with study endpoints * History of previous intraocular surgery in the study eye in the previous 6 months * Refusing or unable to comply with the follow-up schedule * Participation in other interventional therapeutic trial at time of inclusion * Pregnant, breastfeeding, or unable to understand the character and individual consequences of the investigation

Design outcomes

Primary

MeasureTime frame
Far uncorrected visual acuityYear 1
Near best corrected visual acuityYear 1
Intermediate (80cm) best corrected visual acuityYear 1
Far best corrected visual acuityYear 1
Near uncorrected visual acuityYear 1
Intermediate (80cm) uncorrected visual acuityYear 1

Secondary

MeasureTime frameDescription
Tilting sensitivityYear 1
Decentration sensitivityYear 1
Patient satisfactionYear 1Questionnaire
Adverse eventsYear 1Including Posterior Capsule Opacification rates
Contrast sensitivityYear 1

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026